Cargando…
Unfavorable Outcome of Neuroblastoma in Patients With 2p Gain
Background: Amplification of the MYCN oncogene is the most unfavorable genetic factor in neuroblastoma patients. However, knowledge about the clinical impact of low-level multiplication of MYCN is still insufficient. Therefore, we aimed to investigate the disease course in patients with different co...
Autores principales: | Szewczyk, Katarzyna, Wieczorek, Aleksandra, Młynarski, Wojciech, Janczar, Szymon, Woszczyk, Mariola, Gamrot, Zuzanna, Chaber, Radosław, Wysocki, Mariusz, Pogorzała, Monika, Bik-Multanowski, Mirosław, Balwierz, Walentyna |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794702/ https://www.ncbi.nlm.nih.gov/pubmed/31649880 http://dx.doi.org/10.3389/fonc.2019.01018 |
Ejemplares similares
-
Isolated central nervous system relapses in patients with high-risk neuroblastoma -clinical presentation and prognosis: experience of the Polish Paediatric Solid Tumours Study Group
por: Wieczorek, Aleksandra, et al.
Publicado: (2022) -
Late effects in survivors of childhood acute lymphoblastic leukemia in the context of selected gene polymorphisms
por: Kwiecinska, Kinga, et al.
Publicado: (2018) -
Genetic Profiling in Children With Acute Lymphoblastic Leukemia
Referred for Allogeneic Hematopoietic Stem Cell Transplantation
por: Kwiecinska, Kinga, et al.
Publicado: (2022) -
The role of N-Myc gene amplification in neuroblastoma childhood tumour – single-centre experience
por: Kaczówka, Przemysław, et al.
Publicado: (2018) -
Genetic Background of Immune Complications after Allogeneic Hematopoietic Stem Cell Transplantation in Children
por: Skoczen, Szymon, et al.
Publicado: (2016)